Cargando…

Longer Hydroxyurea Administration Prior to Imatinib Mesylate is Risk Factor for Unsuccessful Major Molecular Response in Chronic-Phase Chronic Myeloid Leukemia: Possibility of P-Glycoprotein Role

OBJECTIVE: This study aimed to identify the association between duration of HU administration prior to IM treatment and MMR achievement in chronic-phase CML while evaluating the role of MDA, HIF-1α and P-gp. METHODS: The study was conducted at Dr. Cipto Mangunkusumo National General Hospital and Dha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rinaldi, Ikhwan, Reksodiputro, Ary Harryanto, Jusman, Sri Widia, Harahap, Alida, Setiabudy, Rianto, Wanandi, Septelia Inawati, Tambunan, Karmel, Suharti, Catharina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	West Asia Organization for Cancer Prevention 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7173389/ https://www.ncbi.nlm.nih.gov/pubmed/31870110 http://dx.doi.org/10.31557/APJCP.2019.20.12.3689

Ejemplares similares

Inhibition of ALA dehydratase activity in heme biosynthesis reduces cytoglobin expression which is related to the proliferation and viability of keloid fibroblasts
por: Nauli, Raisa, et al.
Publicado: (2023)

Regulation and Signaling of TGF-β Autoinduction
por: Hariyanto, Narendra Ichiputra, et al.
Publicado: (2021)

Curcumin for the Prevention of Epithelial-Mesenchymal Transition in Endoxifen-Treated MCF-7 Breast Cancer Cells
por: Paramita, P, et al.
Publicado: (2018)

ARID1A Expression is Down-Regulated by Oxidative Stress in Endometriosis and Endometriosis-Associated Ovarian Cancer
por: Winarto, Hariyono, et al.
Publicado: (2017)

Drug Efflux Transporters Are Overexpressed in Short-Term Tamoxifen-Induced MCF7 Breast Cancer Cells
por: Krisnamurti, Desak Gede Budi, et al.
Publicado: (2016)

Neuroglobin correlates with cryptochrome-1 in obstructive sleep apnea with primary aldosteronism
por: Tedjasukmana, Rimawati, et al.
Publicado: (2018)

The Effect of Alpha Mangostin on Epithelial-Mesenchymal Transition on Human Hepatocellular Carcinoma HepG2 Cells Surviving Sorafenib via TGF-β/Smad Pathways
por: Adenina, Syarinta, et al.
Publicado: (2020)

Gene Expression of Molecules Regulating Apoptotic Pathways in Glioblastoma Multiforme Treated with Umbilical Cord Stem Cell Conditioned Medium
por: Hardiany, Novi Silvia, et al.
Publicado: (2019)

Imatinib Mesylate plus Hydroxyurea Chemotherapy for Cerebellar Meningioma in a Belgian Malinois Dog
por: JUNG, Hae-Won, et al.
Publicado: (2014)

Profiling of Gene Expression Associated with Stemness and Aggressiveness of ALDH1A1-Expressing Human Breast Cancer Cells
por: Wanandi, Septelia Inawati, et al.
Publicado: (2019)

Mesenchymal Stem Cell-Derived Extracellular Vesicles Increase Human MCF7 Breast Cancer Cell Proliferation associated with OCT4 Expression and ALDH Activity
por: Zakiyah, Nibras, et al.
Publicado: (2023)

Determining a critical threshold for G6PD activity below which red blood cell response to oxidative stress is poor
por: Swastika, Maria, et al.
Publicado: (2020)

Melatonin effect on hypoxia inducible factor-1α and clinical response in patients with oral squamous cell carcinoma receiving neoadjuvant chemotherapy: A randomized controlled trial
por: Kartini, Diani, et al.
Publicado: (2021)

Resistance Mechanism of Acute Myeloid Leukemia Cells Against Daunorubicin and Cytarabine: A Literature Review
por: Arwanih, Elly Y, et al.
Publicado: (2022)

Differential expression of several drug transporter genes in HepG2 and Huh-7 cell lines
por: Louisa, Melva, et al.
Publicado: (2016)

Metabolic Interplay between Tumour Cells and Cancer-Associated Fibroblasts (CAFs) under Hypoxia versus Normoxia
por: Wanandi, Septelia Inawati, et al.
Publicado: (2018)

Response to imatinib mesylate in childhood chronic myeloid leukemia in chronic phase
por: Linga, Vijay Gandhi, et al.
Publicado: (2014)

The role of the glucocorticoid receptor and its impact on steroid response in moderate-severe COVID-19 patients
por: Aliska, Gestina, et al.
Publicado: (2023)

Moringa oleifera Leaves Extract Ameliorates Doxorubicin-Induced Cardiotoxicity via Its Mitochondrial Biogenesis Modulatory Activity in Rats
por: Patintingan, Cyntia Gracesella, et al.
Publicado: (2023)

In silico and in vitro studies on the anti-cancer activity of andrographolide targeting survivin in human breast cancer stem cells
por: Wanandi, Septelia Inawati, et al.
Publicado: (2020)

Correction: In silico and in vitro studies on the anti-cancer activity of andrographolide targeting survivin in human breast cancer stem cells
por: Wanandi, Septelia Inawati, et al.
Publicado: (2021)

Synergy between Proteasome Inhibitors and Imatinib Mesylate in Chronic Myeloid Leukemia
por: Hu, Zheng, et al.
Publicado: (2009)

Molecular response to imatinib mesylate of Brazilian patients with chronic myeloid leukemia
por: Vieira-Mion, Ana Lucia, et al.
Publicado: (2017)

Kaposi’s sarcoma associated with chronic myeloid leukemia and imatinib mesylate therapy
por: D’Addona, Matteo, et al.
Publicado: (2022)

Mechanisms of Cytotoxicity of Chemical Agents to Giant Cell Tumors: An In Vitro Study
por: Kamal, Achmad Fauzi, et al.
Publicado: (2020)

Platelet Dysfunction in Patients with Chronic Myeloid Leukemia: Does Imatinib Mesylate Improve It?
por: Akay, Olga Meltem, et al.
Publicado: (2016)

Discontinuation of Imatinib Mesylate could Improve Renal Impairment in Chronic Myeloid Leukemia
por: Malkan, Umit Y., et al.
Publicado: (2018)

A Modified Preparation Method of Ideal Platelet-Rich Fibrin Matrix From Whole Blood
por: Reksodiputro, Mirta Hediyati, et al.
Publicado: (2021)

Efficacy of imatinib mesylate-based front-line therapy in pediatric chronic myelogenous leukemia
por: Oh, Hyun Jin, et al.
Publicado: (2013)

Multiple Eruptive Dermatofibromas Secondary to Imatinib Mesylate in a Patient with Chronic Myeloid Leukemia
por: Lira-Valero, Francisco J, et al.
Publicado: (2021)

Long‐term data from a phase 3 study of radotinib versus imatinib in patients with newly diagnosed, chronic myeloid leukaemia in the chronic phase (RERISE)
por: Do, Young Rok, et al.
Publicado: (2020)

Periorbital edema secondary to imatinib mesylate
por: McClelland, Collin M, et al.
Publicado: (2010)

Cutaneous adverse effects of imatinib mesylate
por: Dogu, Mehmet Hilmi, et al.
Publicado: (2015)

The Differential Effects of Propylthiouracil and Methimazole as Graves’ Disease Treatment on Vascular Atherosclerosis Markers: A Randomized Clinical Trial
por: Wisnu, Wismandari, et al.
Publicado: (2021)

Evaluation of the Safety of Imatinib Mesylate in 200 Iraqi Patients with Chronic Myeloid Leukemia in the Chronic Phase: Single-Center Study
por: Matti, Bassam Francis, et al.
Publicado: (2013)

Successful Rechallenge with Imatinib in a Patient with Chronic Myeloid Leukemia Who Previously Experienced Imatinib Mesylate Induced Pneumonitis
por: Go, Seong Woo, et al.
Publicado: (2013)

Conjugation of Cetuximab – Puromycin and Its Target-Specific Effect on Triple Negative Breast Cancer Cell Lines
por: Puspitasari, Diah, et al.
Publicado: (2022)

The role of clopidogrel resistance-related genetic and epigenetic factors in major adverse cardiovascular events among patients with acute coronary syndrome after percutaneous coronary intervention
por: Giantini, Astuti, et al.
Publicado: (2023)

A case of subdural hematoma in patient with chronic myeloid leukemia treated with high-dose imatinib mesylate
por: Kim, Min Sik, et al.
Publicado: (2010)

Comparative study for the efficacy, safety and quality of life in patients of chronic myeloid leukemia treated with Imatinib or Hydroxyurea
por: Jain, Parveen, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_5ghe75gtafbfedhrn25veinse7